How should we use anti-CTLA-4 antibodies?
- PMID: 26613660
- DOI: 10.1016/j.ejca.2015.09.002
How should we use anti-CTLA-4 antibodies?
Comment on
-
Long term survival with cytotoxic T lymphocyte-associated antigen 4 blockade using tremelimumab.Eur J Cancer. 2015 Nov;51(17):2689-97. doi: 10.1016/j.ejca.2015.08.012. Epub 2015 Sep 10. Eur J Cancer. 2015. PMID: 26364516 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
